The results of this randomized trial showed significant neuropathic pain score reduction with the use of lacosamide in patients with Nav1.7 mutations.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content